Cargando…

Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition with uncontrolled activation of lymphocytes and macrophages. Besides a primary (genetic) form, HLH can also be triggered by malignant, autoimmune and infectious diseases. HLH recurrences are rarely described, usual...

Descripción completa

Detalles Bibliográficos
Autores principales: Orth, Hans Martin, Fuchs, Andre, Lübke, Nadine, Jensen, Björn-Erik Ole, Luedde, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233783/
https://www.ncbi.nlm.nih.gov/pubmed/35752863
http://dx.doi.org/10.1186/s12985-022-01841-y
_version_ 1784735879718240256
author Orth, Hans Martin
Fuchs, Andre
Lübke, Nadine
Jensen, Björn-Erik Ole
Luedde, Tom
author_facet Orth, Hans Martin
Fuchs, Andre
Lübke, Nadine
Jensen, Björn-Erik Ole
Luedde, Tom
author_sort Orth, Hans Martin
collection PubMed
description BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition with uncontrolled activation of lymphocytes and macrophages. Besides a primary (genetic) form, HLH can also be triggered by malignant, autoimmune and infectious diseases. HLH recurrences are rarely described, usually only in primary HLH. Parvovirus B19 (PVB19) Infection is one of the rare and rather benign causes of HLH. Since the infection usually results in long-lasting immunity, recurrent viremia is very uncommon. CASE PRESENTATION: We report an unusual case of a young female with recurrent PVB19 infection that led to repeated episodes of HLH. The first episode occurred at the age of 25 years with a three-week history of high fever and nonspecific accompanying symptoms. The diagnosis of HLH was confirmed by HLH-2004 criteria and HScore, PVB19 viremia was detected as underlying cause. Following guideline-based therapy, the patient was symptom-free for one year, before similar symptoms recurred in a milder form. Again, PVB19 was detected and HLH was diagnosed according to HScore. After successful treatment and a nine-month symptom-free interval, a third phase of hyperinflammation with low PVB19 viremia occurred; this time, treatment with a corticosteroid and intravenous immunoglobulin was initiated before the presence of clear diagnostic criteria for HLH. No further events occurred in the following three years. CONCLUSIONS: In the case of our patient, the recurrent viremia triggered three episodes of hyperinflammation, two of which were clearly diagnosed as HLH. To our knowledge, this is the first published case of recurrent HLH due to PVB19 infection. Therefore, the case gives new insights in triggering mechanisms for HLH.
format Online
Article
Text
id pubmed-9233783
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92337832022-06-27 Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis Orth, Hans Martin Fuchs, Andre Lübke, Nadine Jensen, Björn-Erik Ole Luedde, Tom Virol J Case Report BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition with uncontrolled activation of lymphocytes and macrophages. Besides a primary (genetic) form, HLH can also be triggered by malignant, autoimmune and infectious diseases. HLH recurrences are rarely described, usually only in primary HLH. Parvovirus B19 (PVB19) Infection is one of the rare and rather benign causes of HLH. Since the infection usually results in long-lasting immunity, recurrent viremia is very uncommon. CASE PRESENTATION: We report an unusual case of a young female with recurrent PVB19 infection that led to repeated episodes of HLH. The first episode occurred at the age of 25 years with a three-week history of high fever and nonspecific accompanying symptoms. The diagnosis of HLH was confirmed by HLH-2004 criteria and HScore, PVB19 viremia was detected as underlying cause. Following guideline-based therapy, the patient was symptom-free for one year, before similar symptoms recurred in a milder form. Again, PVB19 was detected and HLH was diagnosed according to HScore. After successful treatment and a nine-month symptom-free interval, a third phase of hyperinflammation with low PVB19 viremia occurred; this time, treatment with a corticosteroid and intravenous immunoglobulin was initiated before the presence of clear diagnostic criteria for HLH. No further events occurred in the following three years. CONCLUSIONS: In the case of our patient, the recurrent viremia triggered three episodes of hyperinflammation, two of which were clearly diagnosed as HLH. To our knowledge, this is the first published case of recurrent HLH due to PVB19 infection. Therefore, the case gives new insights in triggering mechanisms for HLH. BioMed Central 2022-06-25 /pmc/articles/PMC9233783/ /pubmed/35752863 http://dx.doi.org/10.1186/s12985-022-01841-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Orth, Hans Martin
Fuchs, Andre
Lübke, Nadine
Jensen, Björn-Erik Ole
Luedde, Tom
Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis
title Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis
title_full Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis
title_fullStr Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis
title_full_unstemmed Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis
title_short Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis
title_sort recurrent parvovirus b19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233783/
https://www.ncbi.nlm.nih.gov/pubmed/35752863
http://dx.doi.org/10.1186/s12985-022-01841-y
work_keys_str_mv AT orthhansmartin recurrentparvovirusb19viremiaresultingintwoepisodesofhemophagocyticlymphohistiocytosis
AT fuchsandre recurrentparvovirusb19viremiaresultingintwoepisodesofhemophagocyticlymphohistiocytosis
AT lubkenadine recurrentparvovirusb19viremiaresultingintwoepisodesofhemophagocyticlymphohistiocytosis
AT jensenbjornerikole recurrentparvovirusb19viremiaresultingintwoepisodesofhemophagocyticlymphohistiocytosis
AT lueddetom recurrentparvovirusb19viremiaresultingintwoepisodesofhemophagocyticlymphohistiocytosis